Crinetics Pharmaceuticals Inc buy Morgan Stanley
Start price
29.09.25
/
50%
€37.40
Target price
29.09.26
€65.69
Performance (%)
10.16%
Price
17:44
€41.20
Summary
This prediction is currently active. The prediction currently has a performance of 10.16%. This prediction currently runs until 29.09.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 1.508% | 1.508% |
| iShares Core DAX® | 0.142% | -1.511% |
| iShares Nasdaq 100 | 0.833% | -2.600% |
| iShares Nikkei 225® | -0.829% | -7.040% |
| iShares S&P 500 | 0.008% | -1.196% |
Comments by Morgan_Stanley for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target raised by analysts at Morgan Stanley from $65.00 to $77.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€44.80
23.05.24
23.05.24
€64.64
23.05.25
23.05.25
-42.86%
24.05.25
24.05.25
